Search Results - "Mateo, Aránzazu García"

Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1‐acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group by Ocio, Enrique M., Motlló, Cristina, Rodríguez‐Otero, Paula, Martínez‐López, Joaquín, Cejalvo, Mª José, Martín‐Sánchez, Jesús, Bladé, Joan, García‐Malo, Mª Dolores, Dourdil, Mª Victoria, García‐Mateo, Aránzazu, Arriba, Felipe, García‐Sanz, Ramón, Rubia, Javier, Oriol, Albert, Lahuerta, Juan‐José, San‐Miguel, Jesús F., Mateos, María‐Victoria

“…Summary This phase I/II trial evaluated the combination of the kinesin spindle protein inhibitor filanesib with pomalidomide and dexamethasone in relapsed or…”
Get full text

Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients by Puertas, Borja, González-Calle, Verónica, Sureda, Anna, Moreno, María José, Oriol, Albert, González, Esther, Rosiñol, Laura, López, Jordi, Escalante, Fernando, Martínez-Lopez, Joaquín, Carrillo, Estrella, Clavero, Esther, Ríos-Tamayo, Rafael, Rey-Bua, Beatriz, González-Rodríguez, Ana Pilar, Dourdil, Victoria, De Arriba, Felipe, González, Sonia, Pérez-de-Oteyza, Jaime, Hernández, Miguel T, García-Mateo, Aránzazu, Bargay, Joan, Bladé, Joan, Lahuerta, Juan José, San Miguel, Jesús F, Ocio, Enrique M, Mateos, María-Victoria

“…In this randomized phase 2 study (GEM-KyCyDex), the combination of weekly carfilzomib 70 mg/m2, cyclophosphamide and dexamethasone was compared to carfilzomib…”
Get full text

Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy by Matarraz, Sergio, Leoz, Pilar, Fernández, Carlos, Colado, Enrique, Chillón, María Carmen, Vidriales, María Belén, González, Marcos, Rivera, Daniel, Osuna, Carlos Salvador, Caballero-Velázquez, Teresa, Van Der Velden, Vincent, Jongen-Lavrencic, Mojca, Gutiérrez, Oliver, Bermejo, Ana Yeguas, Alonso, Luis García, García, Monique Bourgeois, De Ramón Sánchez, Cristina, García-Donas, Gloria, Mateo, Aránzazu García, Recio, Isabel, Sánchez-Real, Javier, Mayado, Andrea, Gutiérrez, María Laura, Bárcena, Paloma, Barrena, Susana, López, Antonio, Van Dongen, Jacques, Orfao, Alberto

“…Severe hemorrhagic events occur in a significant fraction of acute promyelocytic leukemia patients, either at presentation and/or early after starting therapy,…”
Get full text

Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study by Jiménez, Cristina, Prieto-Conde, María Isabel, García-Álvarez, María, Alcoceba, Miguel, Escalante, Fernando, Chillón, María del Carmen, García de Coca, Alfonso, Balanzategui, Ana, Cantalapiedra, Alberto, Aguilar, Carlos, Corral, Rocío, González-López, Tomás, Marín, Luis A., Bárez, Abelardo, Puig, Noemí, García-Mateo, Aránzazu, Gutiérrez, Norma C., Sarasquete, María Eugenia, González, Marcos, García-Sanz, Ramón

“…Immunoglobulin M (IgM) monoclonal gammopathies show considerable variability, involving three different stages of presentation: IgM monoclonal gammopathy of…”
Get full text

Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high risk smoldering multiple myeloma included in the GEM-CESAR trial by Puig, Noemí, Agulló, Cristina, Contreras, Teresa, Pérez, José-Juan, Aires, Irene, Calasanz, María-José, García-Sanz, Ramón, Castro, Sergio, Martínez-López, Joaquín, Rodríguez-Otero, Paula, González-Calle, Verónica, González, Marta S, Oriol, Albert, Gutiérrez, Norma C, Ríos-Tamayo, Rafael, Rosiñol, Laura, Álvarez, Miguel-Ángel, Bargay, Joan, González-Rodríguez, Ana-Pilar, Alegre, Adrián, Escalante, Fernando, Iñigo, María-Belén, De la Rubia, Javier, Teruel, Ana-Isabel, De Arriba, Felipe, Palomera, Luis, Hernández, Miguel T, López-Jiménez, Javier, Reinoso, Marta, García-Mateo, Aránzazu, Ocio, Enrique M, Bladé, Joan, Lahuerta, Juan-José, Cedena, María-Teresa, Paiva, Bruno, Miguel, Jesús F San, Mateos, María-Victoria

“…The value of quantitative immunoprecipitation mass spectrometry (QIP-MS) to identify the M-protein is being investigated in patients with monoclonal…”
Get full text

Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease by Lakhwani, Sunil, Mateos, María Victoria, Martínez-López, Joaquín, Paiva, Bruno, Rosiñol Dachs, Laura, Martínez, Rafael, Oriol, Albert, Bargay, Joan, González-Montes, Yolanda, Gironella, Mercedes, Encinas, Cristina, Martín, Jesús, Jarque, Isidro, Granell, Miquel, Abella, Eugenia, García-Mateo, Aránzazu, Hernández-Rivas, José Ángel, Ramila, Elena, Krsnik, Isabel, Casado Montero, Luis Felipe, De Arriba, Felipe, Palomera, Luis, Sampol, Antonia, Moraleda, José María, Casanova, María, Delgado, Pilar, Lafuente, Ana, Amutio, Elena, López-Martínez, Aurelio, Altés, Albert, Ruíz, M Ángeles, Alegre, Adrián, Lopez-Anglada, Lucia, De La Cruz, Javier, Alonso Fernández, Rafael, Bladé Creixenti, Joan, Lahuerta, Juan-José, San-Miguel, Jesús, Hernández, Miguel-Teodoro

“…Information on the prognostic value of immunoparesis (IP) recovery in multiple myeloma (MM) patients has been only generated in some observational and…”
Get full text

Clinical management and follow-up of relapsed immune thrombotic thrombocytopenic purpura during pregnancy: A case report by Marcellini Antonio, Shally, Valencia Castillo, Sandra, Díaz Valdés, José, Torres Tienza, Ana, Zato Hernández, Esther, García Mateo, Aránzazu, Llorente Melgar, M. Dolores, Olivier Cornacchia, M. Carmen, Queizán Hernández, José Antonio

Get full text

6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival by García‐Sanz, Ramón, Dogliotti, Irene, Zaccaria, Gian Maria, Ocio, Enrique María, Rubio, Araceli, Murillo, Ilda, Escalante, Fernando, Aguilera, Carmen, García‐Mateo, Aránzazu, García de Coca, Alfonso, Hernández, Roberto, Dávila, Julio, Puig, Noemí, García‐Álvarez, María, Chillón, María del Carmen, Alcoceba, Miguel, Medina, Alejandro, González de la Calle, Verónica, Sarasquete, María Eugenia, González, Marcos, Gutiérrez, Norma Carmen, Jiménez, Cristina

“…Summary Deletion of the long arm of chromosome 6 (del6q) is the most frequent cytogenetic abnormality in Waldenström macroglobulinaemia (WM), occurring in…”
Get full text

Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem‐cell transplantation is a prognostic marker of longer progression‐free survival and overall survival by Dávila, Julio, González‐Calle, Verónica, Escalante, Fernando, Cerdá, Seila, Puig, Noemí, García‐Sanz, Ramón, Bárez, Abelardo, Montes, Carmen, López, Rosa, Alonso, José María, Aguilar, Carlos, García‐Mateo, Aránzazu, Labrador, Jorge, Aguilera, Carmen, García‐Coca, Alfonso, Hernández, Roberto, Mateos, María‐Victoria, Ocio, Enrique M.

“…Summary Immunoparesis is the suppression of normal polyclonal immunoglobulins and is present in most patients with newly diagnosed multiple myeloma (MM). The…”
Get full text

B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients by Mendonça de Pontes, Robéria, Flores-Montero, Juan, Sanoja-Flores, Luzalba, Puig, Noemi, Pessoa de Magalhães, Roberto J, Corral-Mateos, Alba, Salgado, Anna Beatriz, García-Sánchez, Omar, Pérez-Morán, José, Mateos, Maria-Victoria, Burgos, Leire, Paiva, Bruno, Te Marvelde, Jeroen, van der Velden, Vincent H J, Aguilar, Carlos, Bárez, Abelardo, García-Mateo, Aranzazú, Labrador, Jorge, Leoz, Pilar, Aguilera-Sanz, Carmen, Durie, Brian, van Dongen, Jacques J M, Maiolino, Angelo, Sobral da Costa, Elaine, Orfao, Alberto

“…B-cell regeneration during therapy has been considered as a strong prognostic factor in multiple myeloma (MM). However, the effects of therapy and hemodilution…”
Get full text

PB2102: IMPACT OF AUTOLOGOUS STEM CELL TRASPLANTATION IN AL AMYLOIDOSIS. EXPERIENCE IN A SINGLE TERTIARY HOSPITAL by Alonso, Elena Alejo, Alonso, David, Navarro, José María, Puertas, Borja, Gómez, Sandra, Hernandez‐Sanchez, Alberto, Puerta, Carlos, García‐Jaén, Pablo, Zapata, Evelyn, Rey‐Búa, Beatriz, Puig, Noemi, Navarro, Almudena, Corral, Lucía López, Eirós, Rocío, Villacorta, Eduardo, Escalante, Fernando, Bárez, Abelardo, García‐Mateo, Aranzazu, Díaz‐Gálvez, Francisco Javier, Alonso, José María, Hernández, Roberto, Coca, Alfonso García, López, Rosa, Mateos, Maria‐Victoria, DE LA Calle, Veronica Gonzalez

Get full text

Isolated and Dynamic Peripheral Blood Residual Disease Status Characterized By Mass Spectrometry Predicts Outcome in Patients with High Risk Smoldering Multiple Myeloma Treated in the GEM-CESAR Trial by Puig, Noemi, Agullo, Cristina, Contreras, Teresa, Paiva, Bruno, Cedena Romero, Maria Teresa, Pérez, José Juan, Aires, Irene, Martinez-Lopez, Joaquin, Rodriguez Otero, Paula, Gonzalez-Calle, Veronica, Gonzalez Perez, Marta Sonia, Gutierrez, Norma C., Rocafiguera, Albert Oriol, Ríos, Rafael, Rosiñol, Laura, Alvarez Rivas, Miguel Angel, Calasanz, Maria Jose, Joan, Bargay, Garcia-Sanz, Ramon, Gonzalez, Ana Pilar, Alegre, Adrián, Escalante, Fernando, Martínez, Rafael, De La Rubia, Javier, Teruel, Ana Isabel, De Arriba, Felipe, Palomera, Luis, Castro, Sergio, Hernández Garcia, Miguel Teodoro, López, Javier, García Mateo, Aránzazu, Ocio, Enrique M, Bladé, Joan, Lahuerta Palacios, Juan Jose, San Miguel, Jesús, Mateos, Maria Victoria

“…Background: GEM-CESAR trial is a potentially curative strategy for high-risk smoldering multiple myeloma (HRsMM) patients (pts) in which the primary endpoint…”
Get full text

Curative Strategy (GEM-CESAR) for High-Risk Smoldering Myeloma (SMM): Post-Hoc Analysis of Sustained Undetectable Measurable Residual Disease (MRD) by Mateos, Maria-Victoria, Martínez-López, Joaquín, Rodríguez-Otero, Paula, San-Miguel, Jesús, Gonzalez-Calle, Veronica, Gonzalez, Marta Sonia, Oriol, Albert, Gutierrez, Norma C., Rios, Rafael, Rosinol Dachs, Laura, Alvarez, Miguel Angel, Bargay, Joan, Gonzalez, Ana Pilar, Escalante, Fernando, Alegre, Adrian, Iñigo, Belén, de la Rubia, Javier, Teruel, Ana Isabel, De Arriba, Felipe, Palomera, Luis, Hernández, Miguel-Teodoro, Lopez Jimenez, Javier, Reinoso Segura, Marta, García Mateo, Aránzazu, Ocio, Enrique M., Bladé, Joan, Lahuerta, Juan-José, Cedena, María Teresa, Puig, Noemi, Paiva, Bruno

Get full text

Prognostic Value of the Hevylite Chain in MGUS Patients in a Population Study by García Mateo, Aránzazu, Mateos, Maria-Victoria, Orfao, Alberto, Contreras Sanfeliciano, Teresa, Contreras Sanfeliciano, Luzalba del Carmen, Caro Narros, Mª Del Rosario, Puig, Noemi, Queizan, José Antonio, Olivier, Carmen

“…Introduction: Studies have shown that a large monoclonal protein (MP) and immunoparesis in MGUS/SMM have predictive value of progression since they may be…”
Get full text

Immunoparesis Recovery in Transplant-Ineligible Newly Diagnosis Multiple Myeloma Patients: An Independent Prognosis Factor That Could Complement Prognostic Value of Minimal Residual Disease by Lakhwani, Sunil, Mateos, María Victoria, Martínez-López, Joaquín, Paiva, Bruno, Rosinol Dachs, Laura, Martínez, Rafael, Oriol, Albert, Bargay, Joan, Gonzalez-Montes, Yolanda, Gironella, Mercedes, Encinas, Cristina, Martin, Jesus, Jarque, Isidro, Granell, Miquel, Abella, Eugenia, García Mateo, Aránzazu, Hernández-Rivas, José Ángel, Ramila, Elena, Krsnik, Isabel, Casado Montero, Luis Felipe, De Arriba, Felipe, Palomera, Luis, Sampol, Antonia, Moraleda, Jose Maria, Casanova, Maria, Delgado, Pilar, Lafuente, Ana, Amutio, Elena, Martínez, Aurelio Lopez, Altés, Albert, Ruíz, M. Ángeles, Lopez-Anglada, Lucia, Bladé Creixenti, Joan, Lahuerta, Juan-José, San-Miguel, Jesús, Hernández, Miguel-Teodoro

Get full text

IgM-Gammopathies Transformed into Aggressive Lymphoma: Incidence, Basal Clinical Features and Outcome of a Registry Based, Spanish Retrospective Series by Dogliotti, Irene, Jiménez, Cristina, Cavallo, Federica, Puig, Noemi, Zaccaria, Gian Maria, Gonzalez De La Calle, Veronica, Sarasquete, Maria Eugenia, Alcoceba, Miguel, Delgado, Pilar, López, Maria Rosa, García Mateo, Aránzazu, Ferrero, Simone, Boccadoro, Mario, González, Marcos, García-Sanz, Ramón

“…Background Transformation into aggressive lymphoma (AL) is a rare complication of indolent lymphoproliferative disorders (LPDs) and is characterized by poor…”
Get full text

Curative Strategy (GEM-CESAR) for High-Risk Smoldering Myeloma (SMM): Carfilzomib, Lenalidomide and Dexamethasone (KRd) As Induction Followed By HDT-ASCT, Consolidation with Krd and Maintenance with Rd by Mateos, Maria-Victoria, Martinez Lopez, Joaquin, Rodríguez-Otero, Paula, Gonzalez-Calle, Veronica, Gonzalez, Marta Sonia, Oriol, Albert, Gutierrez, Norma C., Rios, Rafael, Rosinol, Laura, Alvarez, Miguel Angel, Bargay, Joan, Gonzalez, Ana Pilar, Alegre, Adrian, Escalante, Fernando, Iñigo, Belén, de la Rubia, Javier, Teruel, Ana Isabel, De Arriba, Felipe, Palomera, Luis, Hernández, Miguel-Teodoro, Lopez Jimenez, Javier, García Mateo, Aránzazu, Reinoso Segura, Marta, Ocio, Enrique, Paiva, Bruno, Puig, Noemi, Cedena, María Teresa, Bladé, Joan, Lahuerta, Juan Jose, San-Miguel, Jesús F.

“…Introduction: SMM is an asymptomatic plasma cell disorder with heterogeneous clinical behavior. Both the Spanish Myeloma and ECOG Groups have demonstrated that…”
Get full text

Role of High-Dose Melphalan and Autologous Stem Cell Transplantation in Multiple Myeloma Patients Presenting with t(11;14) by Sobejano, Eduardo, Gonzalez De La Calle, Veronica, Higuero, Victor, Escalante, Fernando, García-Sanz, Ramón, Presa, Daniel, Azibeiro, Raul, Fonseca, Marta, Rey, Beatriz, Puig, Noemi, Gutierrez, Norma C., Leóz, Pilar, Labrador, Jorge, Aguilera, Carmen, Alonso Alonso, Jose Maria, López, Rosa, García Mateo, Aránzazu, Garcia, Alfonso, Hernández, Roberto, Barez Garcia, Abelardo, Dávila, Julio, Redondo, Elena, Quirós, Victor, Mateos, María-Victoria

“…INTRODUCTION The t (11; 14) by fluorescent in situ hybridization (FISH) is found in 15-20% of patients with multiple myeloma (MM) . Although it was classically…”
Get full text

Randomized Phase 2 Study of Weekly Carfilzomib 70 Mg/m2 and Dexamethasone Plus/Minus Cyclophosphamide in Relapsed and/or Refractory Multiple Myeloma (RRMM) Patients (GEM-KyCyDex) by Mateos, Maria-Victoria, Ocio, Enrique M., Sureda Balari, Anna, Oriol, Albert, Garcia, Esther González, Moreno, Maria José, Granell, Miquel, Escalante, Fernando, Gonzalez De La Calle, Veronica, Rosinol Dachs, Laura, Carrillo-Cruz, Estrella, Martínez-López, Joaquín, Dourdil Sahun, Maria Victoria, Gonzalez, Marta Sonia, Perez De Oteyza, Jaime, De Arriba, Felipe, Hernández, Miguel T, García Mateo, Aránzazu, Gonzalez, Ana Pilar, Rios, Rafael, Cabrera, Carmen, Bargay, Juan Jose, Rodriguez-Otero, Paula, Casado, Felipe, Casanova, Maria, Blanchard, María Jesús, Blade Creixenti, Joan, Lahuerta, Juan Jose, San-Miguel, Jesus F.

“…▪ Introduction: Carfilzomib dosed at 56 mg/m2 twice a week in combination with dexamethasone (Kd) is a standard of care for RRMM after 1-3 prior lines (PL)…”
Get full text

OAB-050: Randomized phase 2 study of weekly carfilzomib 70 mg/m2 and dexamethasone plus/minus cyclophosphamide in relapsed and/or refractory multiple (MM) patients (GEMKyCyDex) by Puertas, Borja, González, Verónica, Sureda, Anna, Moreno, Mª José, Oriol, Albert, González, Mª Esther, Rosiñol, Laura, López, Jordi, Escalante, Fernando, López, Joaquín Martinez, Carrillo, Estrella, Clavero, Esther, Rodríguez, Ana Pilar González, Dourdil, Victoria, de la Fuente, Felipe de Arriba, González, Marta Sonia, de Oteyza, Jaime Pérez, Hernández, Miguel teodoro, Mateo, Aránzazu García, Blade, Joan, Palacios, Juan José Lahuerta, San-Miguel, Jesus, Ocio, Enrique, Mateos, María-Victoria

Get full text